XML 70 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity - Additional Information (Detail) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Apr. 06, 2017
Oct. 15, 2015
Oct. 14, 2015
Mar. 30, 2017
Dec. 21, 2016
Mar. 30, 2016
Feb. 15, 2016
Jan. 31, 2016
Nov. 17, 2015
Oct. 18, 2012
Feb. 29, 2016
Jun. 30, 2017
Mar. 31, 2017
Mar. 31, 2016
Dec. 15, 2015
Apr. 29, 2013
Stockholders Equity Note [Line Items]                                
Common Stock, shares authorized                       100,000,000 100,000,000 100,000,000    
Share price $ 9.25                              
Exercise price                         $ 10.00      
Expected term           5 years               6 years    
Expected volatility rate           65.80%               133.00%    
Risk free interest rate           1.20%                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   1,111,111       555,555                    
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 9.00 $ 9.00     $ 10.00             $ 1.1485      
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross                     374,150   149,200 0    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total                       $ 791,000        
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition                       1 year 8 months 16 days 1 year 6 months 11 days      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                       $ 9.71 $ 4.78 $ 5.97    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value                         $ 3.92 $ 0    
Stock Issued During Period, Value, New Issues                           $ 4,999,995    
Debt Conversion, Converted Instrument, Shares Issued       499,000                        
Interest Rate of From Notice of Redemption                         10.00%      
Preferred Stock, Redemption Amount     $ 60,000,000                   $ 60,000,000      
Warrant Expiration Term   5 years       5 years                    
Noncash Or Part Noncash Valuations of Warrant Liability Issued                         2,922,222      
Temporary Equity, Carrying Amount, Attributable to Parent         $ 7,077,778                      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term           5 years               6 years    
Proceeds from Warrant Exercises                         172,000      
Reclassification Of Derivative Liability To Equity         $ 1,177,778               $ 1,177,778 $ 0    
Debt Instrument, Convertible, Conversion Price       $ 10.00                        
Stock Issued During Period, Shares, Exercise of Warrants                         150,000      
Gain (Loss) on Extinguishment of Debt                         $ 0 $ (266,366)    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares               275,000                
Cash Acquired from Acquisition               $ 1,512,500                
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned               $ 200,000                
Common Stock Shares Outstanding                       6,033,518 6,033,518 5,876,852    
Conversion Agreement [Member]                                
Stockholders Equity Note [Line Items]                                
Restricted shares granted to agent                 275,000              
Stock Issued During Period, Shares, New Issues                 275,000              
Shares Issued, Price Per Share                 $ 10              
Rights to Purchase of Common Stock                 300,000              
Interest Payable                 $ 47,112              
Long-term Debt, Gross                 $ 2,000,000              
Conversion Agreement [Member] | Anti Dilution Adjustments [Member]                                
Stockholders Equity Note [Line Items]                                
Restricted shares granted to agent                 200,000              
Stock Issued During Period, Shares, New Issues                 200,000              
Shares Issued, Price Per Share                 $ 20              
NNA [Member]                                
Stockholders Equity Note [Line Items]                                
Share price                 $ 6.00              
Debt Conversion, Converted Instrument, Shares Issued                 600,000              
Debt Conversion, Converted Instrument, Amount                 $ 3,060,000              
Debt Instrument, Convertible, Discount Percentage                 15.00%              
Conversion Of Warrants And Convertible Note                 $ 1,624,029              
Debt Instrument, Convertible, Conversion Price                 $ 5.10              
Debt Instrument, Convertible, Terms of Conversion Feature                 482,904              
Debt Conversion, Original Debt, Amount                 $ 1,124,000              
Gains (Losses) on Restructuring of Debt                 171,000              
Gain (Loss) on Extinguishment of Debt     $ 266,000           $ 266,000              
Southern California Heart Centers, A Medical Corporation [Member]                                
Stockholders Equity Note [Line Items]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                         9.00      
Proceeds from Issuance of Preferred Stock and Preference Stock                         $ 5,000,000      
Series A Preferred Stock [Member]                                
Stockholders Equity Note [Line Items]                                
Restricted shares granted to agent     1,111,111                     0    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 9.00                          
Stock Issued During Period, Value, New Issues                           $ 0    
Preferred Stock, Liquidation Preference Per Share     $ 9.00                          
Preferred Stock, Redemption Amount                         10,000,000      
Stock Issued During Period, Shares, New Issues     1,111,111                     0    
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants, Total                         $ 0 $ 10,000,000    
Stock Issued During Period, Shares, Exercise of Warrants                         0      
Preferred Stock, Conversion Basis                       The Series A Preferred Stock is convertible into Common Stock, at the option of NMM, at any time after issuance at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions. The Series A Preferred Stock is mandatorily convertible not sooner than the earlier to occur of (i) the later of (x) January 31, 2017 or (y) 60 days after the date on which the Company files its quarterly report on Form 10-Q for the period ending September 30, 2016, or (ii) the date on which the Company receives the written, irrevocable decision of NMM not to require a redemption of the Series A Preferred Stock, if the Company receive aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of the Companys equity or convertible securities (other than transactions with NMM). The Company has not received at least $5,000,000 in one or more transactions for the sale of its equity or convertible securities to parties other than NMM.        
Preferred Stock Shares Authorized                       5,000,000 5,000,000      
Preferred Stock, Shares Issued                       1,111,111 1,111,111      
Preferred Stock, Shares Outstanding                       1,111,111 1,111,111      
Series B Preferred Stock [Member]                                
Stockholders Equity Note [Line Items]                                
Restricted shares granted to agent           555,555               555,555    
Expected term                         5 years      
Expected volatility rate                         65.80%      
Risk free interest rate                         1.20%      
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 10.00                    
Stock Issued During Period, Value, New Issues           $ 4,999,995               $ 3,884,745    
Preferred Stock, Liquidation Preference Per Share           $ 9.00                    
Stock Issued During Period, Shares, New Issues           555,555               555,555    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term                         5 years      
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants, Total           $ 3,884,745             $ 0 $ 4,999,995    
Stock Issued During Period, Shares, Exercise of Warrants                         0      
Preferred Stock, Conversion Basis                       (i) at the option of NMM or (ii) mandatorily at any time prior to and including March 30, 2021, if the Company receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of the Companys equity or convertible securities (other than transactions with NMM), at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions. The Company has not received at least $5,000,000 in one or more transactions for the sale of its equity or convertible securities to parties other than NMM.        
Preferred Stock Shares Authorized                       5,000,000 5,000,000 5,000,000    
Preferred Stock, Shares Issued                       555,555 555,555 555,555    
Preferred Stock, Shares Outstanding                       555,555 555,555 555,555    
Private Placement                                
Stockholders Equity Note [Line Items]                                
Restricted shares granted to agent     1,111,111                          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 9.00                          
Stock Issued During Period, Value, New Issues     $ 10,000,000                          
Preferred Stock, Liquidation Preference Per Share     $ 9.00                          
Stock Issued During Period, Shares, New Issues     1,111,111                          
Series B Warrants [Member]                                
Stockholders Equity Note [Line Items]                                
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants, Total           $ 1,115,250                    
Warrant [Member] | Conversion Agreement [Member]                                
Stockholders Equity Note [Line Items]                                
Restricted shares granted to agent                 325,000              
Stock Issued During Period, Shares, New Issues                 325,000              
Maximum                                
Stockholders Equity Note [Line Items]                                
Expected term                         6 years      
Expected volatility rate                         136.04%      
Risk free interest rate                         1.06% 1.94%    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                     $ 6.37   $ 6.00      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term                         6 years      
Minimum                                
Stockholders Equity Note [Line Items]                                
Expected term                         4 years 7 months 6 days      
Expected volatility rate                         126.42%      
Risk free interest rate                         0.75% 1.31%    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                     $ 5.79   $ 4.50      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term                         4 years 7 months 6 days      
9% Senior Subordinated Convertible Notes due February 15, 2016                                
Stockholders Equity Note [Line Items]                                
Convertible notes, interest rate             9.00%           9.00%      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                         82,500      
Debt Conversion, Converted Instrument, Shares Issued             138,463           138,463      
Interest Payable                         $ 554,000      
Debt Instrument, Convertible, Conversion Price                         $ 4.50      
Debt Instrument, Maturity Date             Feb. 15, 2016                  
Debt Conversion, Original Debt, Amount             $ 553,851                  
Directors                                
Stockholders Equity Note [Line Items]                                
Share price $ 9.25                              
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross 80,000                              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 10.18                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 572,000                              
Directors | Maximum                                
Stockholders Equity Note [Line Items]                                
Expected term 6 years                              
Expected volatility rate 134.83%                              
Risk free interest rate 2.09%                              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 6 years                              
Directors | Minimum                                
Stockholders Equity Note [Line Items]                                
Expected term 3 years                              
Expected volatility rate 109.95%                              
Risk free interest rate 1.53%                              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 3 years                              
2010 Equity Incentive Plan                                
Stockholders Equity Note [Line Items]                                
Issuance of common stock for services (shares)                         500,000      
2012 Equity Incentive Plan                                
Stockholders Equity Note [Line Items]                                
Equity incentive plan, additional shares authorized for issuance                   9,000,000            
2013 Equity Incentive Plan                                
Stockholders Equity Note [Line Items]                                
Equity incentive plan, shares authorized for issuance                               500,000
2015 Equity Incentive Plan                                
Stockholders Equity Note [Line Items]                                
Equity incentive plan, shares authorized for issuance                       942,000 1,023,600   1,500,000  
MEZZANINE [Member] | Series A Preferred Stock [Member]                                
Stockholders Equity Note [Line Items]                                
Temporary Equity, Carrying Amount, Attributable to Parent                         $ 0 $ 7,077,778    
Preferred Stock Shares Authorized                           5,000,000    
Preferred Stock, Shares Issued                           1,111,111    
Preferred Stock, Shares Outstanding                           1,111,111